Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells

Virology

Volumn 251, Issue 1, 1998, Pages 38-48

  Stauber, Roland H ^a   Afonina, Elena ^a   Gulnik, Sergei ^b   Erickson, John ^b   Pavlakis, George N ^a  

^a Basic Research Laboratory   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032506209     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9295     Document Type: Article

References (35)

1. Benko D. M., Robinson R., Solomin L., Mellini M., Felber B. K., Pavlakis G. N. Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA. New Biol. 2:1990;1111-1122.
2. Berger J., Aepinus C., Dobrovnik M., Fleckenstein B., Hauber J., Bohnlein E. Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein. Virology. 183:1991;630-635.
3. Bevec D., Jaschke H., Oft M., Woehl T., Himmelspach M., Pacher A., Schebesta M., Koettnitz K., Dobrovnik M., Csonga R., Lottspeich F., Hauber J. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science. 271:1996;1858-1860.
4. Cochrane A. W., Perkins A., Rosen C. A. Identification of sequences important in the nucleolar localization of human immunodeficiencyvirus Rev: Relevance of nucleolar localization to function. J. Virol. 64:1990;881-885.
5. Cullen B. R. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 65:1991;1053-1056.
6. D'Agostino D. M., Ciminale V., Pavlakis G. N., Chieco-Bianchi L. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: Involvement of continued rRNA synthesis in nuclear retention. AIDS Res. Hum. Retroviruses. 11:1995;1063-1072.
7. Felber B. K. Regulation of mRNA expression in HIV-1 and other retroviruses. mRNA Matabolism and Post-Transcriptional Gene Regulation. 1997;Wiley-Liss, New York. p. 323-340.
8. Felber B. K., Drysdale C. M., Pavlakis G. N. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J. Virol. 64:1990;3734-3741.
9. Fornerod M., Ohno M., Yoshida M., Mattaj I. W. CRM1 is an export receptor for leusin-rich nuclear export signals. Cell. 90:1997;1051-1060.
10. Furuta R. A., Kubota S., Maki M., Miyazaki Y., Hattori T., Hatanaka M. Use of a human immunodeficiency virus Type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. J. Virol. 69:1995;1591-1599.
11. Hammerschmid M., Palmeri D., Ruhl M., Jaksche H., Weichselbraun I., Bohnlein E., Malim M. H., Hauber J. Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator. J. Virol. 68:1994;7329-7335.
12. Hope T. J. Viral RNA export. Curr. Biol. 4:1997;335-344.
13. Hope T. J., Klein N. P., Elder M. E., Parslow T. G. trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes. J. Virol. 66:1992;1849-1855.
14. Katahira J., Ishizaki T., Adachi A., Yamamoto K., Shida H. Effects on translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding. J. Virol. 69:1995;3125-3133.
15. Kubota S., Furuta R., Maki M., Hatanaka M. Inhibition of human immunodeficiency virus type 1 Rev function by a Rev mutant which interferes with nuclear/nucleolar localization of Rev. J. Virol. 66:1992;2510-2513.
16. Kubota S., Siomi H., Satoh T., Endo S., Maki M., Hatanaka K. Functional similarity of HIV-Irevrexrev. Biochem. Biophys. Res. Commun. 162:1989;963-970.
17. Lam W.-C., Seifert J. M., Amberger F., Graf C., Auer M., Millar D. P. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S-RNA. Biochemistry. 1998.
18. Lee, S. Neumann, M. Stauber, R. H. Pause, A. Zhou, S. Linehan, W. M. Pavlakis, G. N. Klausner, R. 1998, Transcription dependent nuclear/cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein linked to the green fluorescent protein.
19. Madore S. J., Tiley L. S., Malim M. H., Cullen B. R. Sequence requirements for Rev multimerization in vivo. Virology. 202:1994;186-194.
20. Malim M. H., Böhnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Revtranstrans. Cell. 58:1989;205-214.
21. Malim M. H., Freimuth W. W., Liu J., Boyle T. J., Lyerly H. K., Cullen B. R., Nabel G. J. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176:1992;1197-1201.
22. Mermer B., Felber B. K., Campbell M., Pavlakis G. N. Identification oftrans. Nucleic Acids Res. 18:1990;2037-2044.
23. Nabel G. J., Fox B. A., Post L., Thompson C. B., Woffendin C. A molecular genetic intervention for AIDS effects of a transdominant negative form of Rev. Hum. Gene Ther. 5:1994;79-92.
24. Olsen H. S., Cochrane A. W., Dillon P. J., Nalin C. M., Rosen C. A. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region inenv. Genes Dev. 4:1990;1357-1364.
25. Palm G. J., Zdanow A., Gaitanaris G. A., Stauber R. H., Pavlakis G. N., Wlodawer A. The structural basis for spectral variations in green fluorescent protein. Nat. Struct. Biol. 4:1996;361-365.
26. Parslow T. C. Post-transcriptional regulation of human retroviral gene expression. Human Retroviruses. 1993;IRL Press, Durham. p. 101-136.
27. Pavlakis G. N. The molecular biology of Human Immunodeficiency Virus Type 1. DeVita V. T., Hellman S., Rosenberg S. A. AIDS: Biology, Diagnosis, Treatment and Prevention. 1997;45-74 Lippincott-Raven Publishers, Philadelphia.
28. Schwartz S., Campbell M., Nasioulas G., Harrison J., Felber B. K., Pavlakis G. N. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:1992;7176-7182.
29. Stauber R., Gaitanaris G. A., Pavlakis G. N. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using Green Fluorescent Protein fusions: Transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology. 213:1995;439-449.
30. Stauber R. H., Horie K., Carney P., Hudson E. A., Tarasova N. I., Gaitanaris G. A., Pavlakis G. N. Development and applications of enhanced green fluorescent protein mutants. BioTechniques. 24:1998;462-471.
31. Szilvay A. M., Brokstad K. A., Boe S.-O., Haukenes G., Kalland K. H. Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology. 235:1997;73-81.
32. Szilvay A. M., Brokstad K. A., Kopperud R., Haukenes G., Kalland K. H. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. J. Virol. 69:1995;3315-3323.
33. Thomas S. L., Hauber J., Casari G. Probing the structure of the HIV-1 Rev trans-activator protein by functional analysis. Protein Eng. 10:1997;103-107.
34. Thomas S. L., Oft M., Jaksche H., Casari G., Heger P., Dobrovnik M., Bevec D., Hauber J. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. J. Virol. 72:1998;2935-2944.
35. Zapp M. L., Hope T. J., Parslow T. G., Green M. R. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: A dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci USA. 1991.